Apoptosis signal-regulating kinase 1 is an intracellular inducer of p38 MAPK-mediated myogenic signalling in cardiac myoblasts

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1813, Issue 8, 2011, Pages 1412-1421

  Choi, Tae Gyu ^a   Lee, Jisun ^a   Ha, Joohun ^a   Kim, Sung Soo ^a  

^a Kyung Hee University   (South Korea)

Author keywords

MAPK; ASK1; Myogenic differentiation; Trx

Indexed keywords

APOPTOSIS SIGNAL REGULATING KINASE 1; HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 6; MITOGEN ACTIVATED PROTEIN KINASE P38; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; EMBRYO; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REGULATION; HEART DEVELOPMENT; HEART MUSCLE CELL; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; FEEDBACK, PHYSIOLOGICAL; HYDROGEN PEROXIDE; MAP KINASE KINASE KINASE 5; MAP KINASE SIGNALING SYSTEM; MUSCLE DEVELOPMENT; MYOBLASTS, CARDIAC; OXIDATION-REDUCTION; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; THIOREDOXINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79959334421     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2011.04.001     Document Type: Article

References (76)

1. Blais A., Tsikitis M., Acosta-Alvear D., Sharan R., Kluger Y., Dynlacht B.D. An initial blueprint for myogenic differentiation. Genes Dev. 2005, 19:553-569.
2. Cabane C., Englaro W., Yeow K., Ragno M., Derijard B. Regulation of C2C12 myogenic terminal differentiation by MKK3/p38alpha pathway. Am. J. Physiol. Cell Physiol. 2003, 284:C658-C666.
3. de Angelis L., Zhao J., Andreucci J.J., Olson E.N., Cossu G., McDermott J.C. Regulation of vertebrate myotome development by the p38 MAP kinase-MEF2 signaling pathway. Dev. Biol. 2005, 283:171-179.
4. Puri P.L., Wu Z., Zhang P., Wood L.D., Bhakta K.S., Han J., Feramisco J.R., Karin M., Wang J.Y. Induction of terminal differentiation by constitutive activation of p38 MAP kinase in human rhabdomyosarcoma cells. Genes Dev. 2000, 14:574-584.
5. Wu Z., Woodring P.J., Bhakta K.S., Tamura K., Wen F., Feramisco J.R., Karin M., Wang J.Y., Puri P.L. p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps. Mol. Cell. Biol. 2000, 20:3951-3964.
6. Shapiro L., Puren A.J., Barton H.A., Novick D., Peskind R.L., Shenkar R., Gu Y., Su M.S., Dinarello C.A. Interleukin 18 stimulates HIV type 1 in monocytic cells. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:12550-12555.
7. Pietersma A., Tilly B.C., Gaestel M., de Jong N., Lee J.C., Koster J.F., Sluiter W. p38 mitogen activated protein kinase regulates endothelial VCAM-1 expression at the post-transcriptional level. Biochem. Biophys. Res. Commun. 1997, 230:44-48.
8. Han J., Lee J.D., Bibbs L., Ulevitch R.J. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 1994, 265:808-811.
9. Rouse J., Cohen P., Trigon S., Morange M., Alonso-Llamazares A., Zamanillo D., Hunt T., Nebreda A.R. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 1994, 78:1027-1037.
10. Freshney N.W., Rawlinson L., Guesdon F., Jones E., Cowley S., Hsuan J., Saklatvala J. Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27. Cell 1994, 78:1039-1049.
11. Raingeaud J., Gupta S., Rogers J.S., Dickens M., Han J., Ulevitch R.J., Davis R.J. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 1995, 270:7420-7426.
12. Lee J.C., Laydon J.T., McDonnell P.C., Gallagher T.F., Kumar S., Green D., McNulty D., Blumenthal M.J., Heys J.R., Landvatter S.W., et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994, 372:739-746.
13. Shalom-Barak T., Quach J., Lotz M. Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-kappaB. J. Biol. Chem. 1998, 273:27467-27473.
14. Foltz I.N., Lee J.C., Young P.R., Schrader J.W. Hemopoietic growth factors with the exception of interleukin-4 activate the p38 mitogen-activated protein kinase pathway. J. Biol. Chem. 1997, 272:3296-3301.
15. Lundberg I.E., Dastmalchi M. Possible pathogenic mechanisms in inflammatory myopathies. Rheum. Dis. Clin. North Am. 2002, 28:799-822.
16. Reid M.B., Li Y.P. Cytokines and oxidative signalling in skeletal muscle. Acta Physiol. Scand. 2001, 171:225-232.
17. Chen S.E., Gerken E., Zhang Y., Zhan M., Mohan R.K., Li A.S., Reid M.B., Li Y.P. Role of TNF-{alpha} signaling in regeneration of cardiotoxin-injured muscle. Am. J. Physiol. Cell Physiol. 2005, 289:C1179-C1187.
18. Warren G.L., Hulderman T., Jensen N., McKinstry M., Mishra M., Luster M.I., Simeonova P.P. Physiological role of tumor necrosis factor alpha in traumatic muscle injury. FASEB J. 2002, 16:1630-1632.
19. Li Y.P., Schwartz R.J. TNF-alpha regulates early differentiation of C2C12 myoblasts in an autocrine fashion. FASEB J. 2001, 15:1413-1415.
20. Guttridge D.C., Mayo M.W., Madrid L.V., Wang C.Y., Baldwin A.S. NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 2000, 289:2363-2366.
21. Langen R.C., Schols A.M., Kelders M.C., Van Der Velden J.L., Wouters E.F., Janssen-Heininger Y.M. Tumor necrosis factor-alpha inhibits myogenesis through redox-dependent and -independent pathways. Am. J. Physiol. Cell Physiol. 2002, 283:C714-C721.
22. Langen R.C., Schols A.M., Kelders M.C., Wouters E.F., Janssen-Heininger Y.M. Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappaB. FASEB J. 2001, 15:1169-1180.
23. Saghizadeh M., Ong J.M., Garvey W.T., Henry R.R., Kern P.A. The expression of TNF alpha by human muscle. Relationship to insulin resistance. J. Clin. Invest. 1996, 97:1111-1116.
24. Kuru S., Inukai A., Kato T., Liang Y., Kimura S., Sobue G. Expression of tumor necrosis factor-alpha in regenerating muscle fibers in inflammatory and non-inflammatory myopathies. Acta Neuropathol. 2003, 105:217-224.
25. Chen S.E., Jin B., Li Y.P. TNF-alpha regulates myogenesis and muscle regeneration by activating p38 MAPK. Am. J. Physiol. Cell Physiol. 2007, 292:C1660-C1671.
26. Lo Y.Y., Cruz T.F. Involvement of reactive oxygen species in cytokine and growth factor induction of c-fos expression in chondrocytes. J. Biol. Chem. 1995, 270:11727-11730.
27. Lo Y.Y., Wong J.M., Cruz T.F. Reactive oxygen species mediate cytokine activation of c-Jun NH2-terminal kinases. J. Biol. Chem. 1996, 271:15703-15707.
28. Radeke H.H., Meier B., Topley N., Floge J., Habermehl G.G., Resch K. Interleukin 1-alpha and tumor necrosis factor-alpha induce oxygen radical production in mesangial cells. Kidney Int. 1990, 37:767-775.
29. Sundaresan M., Yu Z.X., Ferrans V.J., Sulciner D.J., Gutkind J.S., Irani K., Goldschmidt-Clermont P.J., Finkel T. Regulation of reactive-oxygen-species generation in fibroblasts by Rac1. Biochem. J. 1996, 318(Pt 2):379-382.
30. Hansen J.M., Zhang H., Jones D.P. Mitochondrial thioredoxin-2 has a key role in determining tumor necrosis factor-alpha-induced reactive oxygen species generation, NF-kappaB activation, and apoptosis. Toxicol. Sci. 2006, 91:643-650.
31. Gao X., Zhang H., Belmadani S., Wu J., Xu X., Elford H., Potter B.J., Zhang C. Role of TNF-alpha-induced reactive oxygen species in endothelial dysfunction during reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 2008, 295:H2242-H2249.
32. Sulciner D.J., Irani K., Yu Z.X., Ferrans V.J., Goldschmidt-Clermont P., Finkel T. rac1 regulates a cytokine-stimulated, redox-dependent pathway necessary for NF-kappaB activation. Mol. Cell. Biol. 1996, 16:7115-7121.
33. Forman H.J., Fukuto J.M., Torres M. Redox signaling: thiol chemistry defines which reactive oxygen and nitrogen species can act as second messengers. Am. J. Physiol. Cell Physiol. 2004, 287:C246-C256.
34. Li J., Stouffs M., Serrander L., Banfi B., Bettiol E., Charnay Y., Steger K., Krause K.H., Jaconi M.E. The NADPH oxidase NOX4 drives cardiac differentiation: role in regulating cardiac transcription factors and MAP kinase activation. Mol. Biol. Cell 2006, 17:3978-3988.
35. Sauer H., Rahimi G., Hescheler J., Wartenberg M. Role of reactive oxygen species and phosphatidylinositol 3-kinase in cardiomyocyte differentiation of embryonic stem cells. FEBS Lett. 2000, 476:218-223.
36. Su B., Mitra S., Gregg H., Flavahan S., Chotani M.A., Clark K.R., Goldschmidt-Clermont P.J., Flavahan N.A. Redox regulation of vascular smooth muscle cell differentiation. Circ. Res. 2001, 89:39-46.
37. Xiao Q.Z., Luo Z.L., Pepe A.E., Margariti A., Zeng L.F., Xu Q.B. Embryonic stem cell differentiation into smooth muscle cells is mediated by Nox4-produced H2O2. Am. J. Physiol. Cell Physiol. 2009, 296:C711-C723.
38. Ichijo H., Nishida E., Irie K., ten Dijke P., Saitoh M., Moriguchi T., Takagi M., Matsumoto K., Miyazono K., Gotoh Y. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 1997, 275:90-94.
39. Chang H.Y., Nishitoh H., Yang X., Ichijo H., Baltimore D. Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adapter protein Daxx. Science 1998, 281:1860-1863.
40. Nishitoh H., Saitoh M., Mochida Y., Takeda K., Nakano H., Rothe M., Miyazono K., Ichijo H. ASK1 is essential for JNK/SAPK activation by TRAF2. Mol. Cell 1998, 2:389-395.
41. Liu H., Nishitoh H., Ichijo H., Kyriakis J.M. Activation of apoptosis signal-regulating kinase 1 (ASK1) by tumor necrosis factor receptor-associated factor 2 requires prior dissociation of the ASK1 inhibitor thioredoxin. Mol. Cell. Biol. 2000, 20:2198-2208.
42. Takeda K., Matsuzawa A., Nishitoh H., Ichijo H. Roles of MAPKKK ASK1 in stress-induced cell death. Cell Struct. Funct. 2003, 28:23-29.
43. Liu H., Zhang H., Iles K.E., Rinna A., Merrill G., Yodoi J., Torres M., Forman H.J. The ADP-stimulated NADPH oxidase activates the ASK-1/MKK4/JNK pathway in alveolar macrophages. Free Radic. Res. 2006, 40:865-874.
44. Saitoh M., Nishitoh H., Fujii M., Takeda K., Tobiume K., Sawada Y., Kawabata M., Miyazono K., Ichijo H. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 1998, 17:2596-2606.
45. Shibanuma M., Kuroki T., Nose K. Stimulation by hydrogen peroxide of DNA synthesis, competence family gene expression and phosphorylation of a specific protein in quiescent Balb/3T3 cells. Oncogene 1990, 5:1025-1032.
46. Beckman K.B., Ames B.N. The free radical theory of aging matures. Physiol. Rev. 1998, 78:547-581.
47. Choi K.J., Piao Y.J., Lim M.J., Kim J.H., Ha J., Choe W., Kim S.S. Overexpressed cyclophilin A in cancer cells renders resistance to hypoxia- and cisplatin-induced cell death. Cancer Res. 2007, 67:3654-3662.
48. Cuenda A., Cohen P. Stress-activated protein kinase-2/p38 and a rapamycin-sensitive pathway are required for C2C12 myogenesis. J. Biol. Chem. 1999, 274:4341-4346.
49. Zetser A., Gredinger E., Bengal E. p38 mitogen-activated protein kinase pathway promotes skeletal muscle differentiation. Participation of the Mef2c transcription factor. J. Biol. Chem. 1999, 274:5193-5200.
50. Imoto K., Kukidome D., Nishikawa T., Matsuhisa T., Sonoda K., Fujisawa K., Yano M., Motoshima H., Taguchi T., Tsuruzoe K., Matsumura T., Ichijo H., Araki E. Impact of mitochondrial reactive oxygen species and apoptosis signal-regulating kinase 1 on insulin signaling. Diabetes 2006, 55:1197-1204.
51. Frey R.S., Rahman A., Kefer J.C., Minshall R.D., Malik A.B. PKCzeta regulates TNF-alpha-induced activation of NADPH oxidase in endothelial cells. Circ. Res. 2002, 90:1012-1019.
52. Basuroy S., Bhattacharya S., Leffler C.W., Parfenova H. Nox4 NADPH oxidase mediates oxidative stress and apoptosis caused by TNF-alpha in cerebral vascular endothelial cells. Am. J. Physiol. Cell Physiol. 2009, 296:C422-C432.
53. Lee K.H., Kim D.G., Shin N.Y., Song W.K., Kwon H., Chung C.H., Kang M.S. NF-kappaB-dependent expression of nitric oxide synthase is required for membrane fusion of chick embryonic myoblasts. Biochem. J. 1997, 324(Pt 1):237-242.
54. Kaliman P., Canicio J., Testar X., Palacin M., Zorzano A. Insulin-like growth factor-II, phosphatidylinositol 3-kinase, nuclear factor-kappaB and inducible nitric-oxide synthase define a common myogenic signaling pathway. J. Biol. Chem. 1999, 274:17437-17444.
55. Keren A., Bengal E., Frank D. p38 MAP kinase regulates the expression of XMyf5 and affects distinct myogenic programs during Xenopus development. Dev. Biol. 2005, 288:73-86.
56. Baeza-Raja B., Munoz-Canoves P. p38 MAPK-induced nuclear factor-kappaB activity is required for skeletal muscle differentiation: role of interleukin-6. Mol. Biol. Cell 2004, 15:2013-2026.
57. Bhat N.R., Feinstein D.L., Shen Q., Bhat A.N. p38 MAPK-mediated transcriptional activation of inducible nitric-oxide synthase in glial cells. Roles of nuclear factors, nuclear factor kappa B, cAMP response element-binding protein, CCAAT/enhancer-binding protein-beta, and activating transcription factor-2. J. Biol. Chem. 2002, 277:29584-29592.
58. Chun Y.K., Kim J., Kwon S., Choi S.H., Hong F., Moon K., Kim J.M., Choi S.L., Kim B.S., Ha J., Kim S.S. Phosphatidylinositol 3-kinase stimulates muscle differentiation by activating p38 mitogen-activated protein kinase. Biochem. Biophys. Res. Commun. 2000, 276:502-507.
59. Matsuzawa A., Saegusa K., Noguchi T., Sadamitsu C., Nishitoh H., Nagai S., Koyasu S., Matsumoto K., Takeda K., Ichijo H. ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity. Nat. Immunol. 2005, 6:587-592.
60. Davis R.J. Signal transduction by the JNK group of MAP kinases. Cell 2000, 103:239-252.
61. Takeda K., Matsuzawa A., Nishitoh H., Tobiume K., Kishida S., Ninomiya-Tsuji J., Matsumoto K., Ichijo H. Involvement of ASK1 in Ca2+αinduced p38 MAP kinase activation. EMBO Rep. 2004, 5:161-166.
62. Tobiume K., Matsuzawa A., Takahashi T., Nishitoh H., Morita K., Takeda K., Minowa O., Miyazono K., Noda T., Ichijo H. ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep. 2001, 2:222-228.
63. Liu Y., Yin G., Surapisitchat J., Berk B.C., Min W. Laminar flow inhibits TNF-induced ASK1 activation by preventing dissociation of ASK1 from its inhibitor 14-3-3. J. Clin. Invest. 2001, 107:917-923.
64. Zhang R., He X., Liu W., Lu M., Hsieh J.T., Min W. AIP1 mediates TNF-alpha-induced ASK1 activation by facilitating dissociation of ASK1 from its inhibitor 14-3-3. J. Clin. Invest. 2003, 111:1933-1943.
65. Zhan M., Jin B., Chen S.E., Reecy J.M., Li Y.P. TACE release of TNF-alpha mediates mechanotransduction-induced activation of p38 MAPK and myogenesis. J. Cell Sci. 2007, 120:692-701.
66. Nakashima J., Tachibana M., Ueno M., Baba S., Tazaki H. Tumor necrosis factor and coagulopathy in patients with prostate cancer. Cancer Res. 1995, 55:4881-4885.
67. Vreugdenhil G., Lowenberg B., Van Eijk H.G., Swaak A.J. Tumor necrosis factor alpha is associated with disease activity and the degree of anemia in patients with rheumatoid arthritis. Eur. J. Clin. Invest. 1992, 22:488-493.
68. Federici M., Hribal M.L., Menghini R., Kanno H., Marchetti V., Porzio O., Sunnarborg S.W., Rizza S., Serino M., Cunsolo V., Lauro D., Mauriello A., Smookler D.S., Sbraccia P., Sesti G., Lee D.C., Khokha R., Accili D., Lauro R. Timp3 deficiency in insulin receptor-haploinsufficient mice promotes diabetes and vascular inflammation via increased TNF-alpha. J. Clin. Invest. 2005, 115:3494-3505.
69. Lee J., Choi K.J., Lim M.J., Hong F., Choi T.G., Tak E., Lee S., Kim Y.J., Chang S.G., Cho J.M., Ha J., Kim S.S. Proto-oncogenic H-Ras, K-Ras, and N-Ras are involved in muscle differentiation via phosphatidylinositol 3-kinase. Cell Res. 2010, 20:919-934.
70. Lim M.J., Seo Y.H., Choi K.J., Cho C.H., Kim B.S., Kim Y.H., Lee J., Lee H., Jung C.Y., Ha J., Kang I., Kim S.S. Suppression of c-Src activity stimulates muscle differentiation via p38 MAPK activation. Arch. Biochem. Biophys. 2007, 465:197-208.
71. Lee J., Hong F., Kwon S., Kim S.S., Kim D.O., Kang H.S., Lee S.J., Ha J. Activation of p38 MAPK induces cell cycle arrest via inhibition of Raf/ERK pathway during muscle differentiation. Biochem. Biophys. Res. Commun. 2002, 298:765-771.
72. Piao Y.J., Seo Y.H., Hong F., Kim J.H., Kim Y.J., Kang M.H., Kim B.S., Jo S.A., Jo I., Jue D.M., Kang I., Ha J., Kim S.S. Nox 2 stimulates muscle differentiation via NF-kappaB/iNOS pathway. Free Radic. Biol. Med. 2005, 38:989-1001.
73. Goossens V., Grooten J., De Vos K., Fiers W. Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:8115-8119.
74. Garcia-Ruiz C., Colell A., Mari M., Morales A., Fernandez-Checa J.C. Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species. Role of mitochondrial glutathione. J. Biol. Chem. 1997, 272:11369-11377.
75. Wenzel P., Mollnau H., Oelze M., Schulz E., Wickramanayake J.M., Muller J., Schuhmacher S., Hortmann M., Baldus S., Gori T., Brandes R.P., Munzel T., Daiber A. First evidence for a crosstalk between mitochondrial and NADPH oxidase-derived reactive oxygen species in nitroglycerin-triggered vascular dysfunction. Antioxid. Redox Signal. 2008, 10:1435-1447.
76. Lee S.B., Bae I.H., Bae Y.S., Um H.D. Link between mitochondria and NADPH oxidase 1 isozyme for the sustained production of reactive oxygen species and cell death. J. Biol. Chem. 2006, 281:36228-36235.